MS Relapses: Just the Tip of the Iceberg

Emerging science is shaking up what has been previously known about multiple sclerosis (MS), changing our understanding of the basic biology of the di…

NIHR launches phase two of its Shape the Future campaign

The National Institute for Health and Care Research (NIHR) has announced the launch of its NHS 75: Shape the Future campaign to shape future healthcar…

Why are FSP models gaining traction within clinical research?

Holding more than 25 years of experience in the medical sector spread across numerous pharmaceutical and CRO-based clinical research roles, Edel Shaw …

Rapid rollout of NHS blood-thinning drugs has saved thousands of lives

Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented

The NHS has revealed that thousands of lives have been saved and around …

Lilly, Boehringer run 'It takes 2' campaign with hip-hop artist Rob Base for kidney disease awarenessThe obesity drug effect: What medical device executives are saying

Jardiance development partners Eli Lilly and Boehringer Ingelheim say it takes two: two tests, to be exact, to find out about a patient’s kidney disea…

Dr Know

The world we’re living in is changing rapidly and the future of health is being profoundly shaped by several interconnected factors.

Five Trends Set to Disrupt Health Marketing in 2024

The media marketplace’s shifting dynamics have reached tectonic proportion with reshuffles at emergent platforms and effects of union strikes shaking …

Vertex gearing up for launch as sickle cell therapy review advances

By early December, the Food and Drug Administration will decide on approval of a genetic medicine for sickle cell disease, potentially offering people…

Moods change with the months? Bausch has a seasonal depression drug TV campaign for you

With the nights drawing in, Bausch Health is taking the plunge on the first-ever TV spot for its seasonal affective disorder (SAD) drug Aplenzin. The …

UK launches its first national PET imaging platform for drug discovery

NPIP will transform medical research and provide better outcomes for patients

The Medicines Discovery Catapult (MDC), the Medical Research Council (M…

Astellas starts Veozah TV push, pitching menopause drug as how to go from hot flashes to not flashes

Astellas’ mission to turn menopause drug Veozah into a major product is ratcheting up a gear, with the drugmaker hitting go on a TV spot centered on h…

Trials of the century

Overcoming operational hurdles and igniting clinical trials

In an era characterised by remarkable breakthroughs in drug discovery, development and bi…

Site Enablement: How Sponsors and CROs Can Enhance Their Clinical Trials in a Competitive Landscape

The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the …

Opening doors

Following in their footsteps – the young people choosing to follow their parents into the pharmaceutical industry

Pharma has changed a lot in recent …

J&J to phase out Janssen name in corporate rebrand

Janssen, a brand name that for six decades has been emblazoned on Johnson & Johnson’s pharmaceutical laboratories and prescription drugs, will be …

NICE gives green light for MSD's Keytruda

The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study

MSD has revealed that the National Institute for Health and…

Biogen kicks off 1,000 layoffs as part of CEO Chris Viehbacher's 'complete redesign'

It was only last spring that Biogen started a round of layoffs that eventually shrank the company’s head count by nearly 900 people last year. Now, a …

Men with enlarged prostates offered robotic treatment by fourth University Hospital

Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue

The Norfolk and Norwich University Hospitals (NNUH) Urolog…